Cite
HARVARD Citation
Calza, L. et al. (2019). Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients. Journal of antimicrobial chemotherapy. pp. 731-738. [Online].